Literature DB >> 15935412

Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria.

Isabelle M Medana1, Ralf-Björn Lindert, Ulrich Wurster, Tran Tinh Hien, Nicholas P J Day, Nguyen Hoan Phu, Nguyen Thi Hoang Mai, Ly Van Chuong, Tran Thi Hong Chau, Gareth D H Turner, Jeremy J Farrar, Nicholas J White.   

Abstract

A retrospective study of cerebrospinal fluid (CSF) markers of brain parenchymal damage was conducted in Vietnamese adults with severe malaria. Three markers were analysed by immunoassays: the microtubule-associated protein tau, for degenerated axons; neuron-specific enolase (NSE), for neurons; and S100B for astrocytes. The mean concentration of tau proteins in the CSF was significantly raised in patients with severe malaria compared with controls (P=0.0003) as reported for other central nervous system diseases. By contrast, the mean concentration of NSE and S100B remained within the normal range. Tau levels were associated with duration of coma (P=0.004) and S100B was associated with convulsions (P=0.006). Concentrations of axonal and astrocyte degeneration markers also were associated with vital organ dysfunction. No association was found between the level of markers of brain parenchymal damage on admission and a fatal outcome. On admission to hospital, patients with severe malaria had biochemical evidence of brain parenchymal damage predominantly affecting axons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935412     DOI: 10.1016/j.trstmh.2004.11.017

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

2.  Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria.

Authors:  Dibyadyuti Datta; Andrea L Conroy; Peter F Castelluccio; John M Ssenkusu; Gregory S Park; Robert O Opoka; Paul Bangirana; Richard Idro; Andrew J Saykin; Chandy C John
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

Review 3.  Human malarial disease: a consequence of inflammatory cytokine release.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva; William B Cowden
Journal:  Malar J       Date:  2006-10-10       Impact factor: 2.979

4.  Transient lesion in the splenium of the corpus callosum in acute uncomplicated falciparum malaria.

Authors:  Jiraporn Laothamatas; Christina L Sammet; Xavier Golay; Marc Van Cauteren; Varinee Lekprasert; Noppadon Tangpukdee; Srivicha Krudsood; Wattana Leowattana; Polrat Wilairatana; Srirama V Swaminathan; Robert L DeLaPaz; Truman R Brown; Sornchai Looareesuwan; Gary M Brittenham
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

5.  Evidence of Brain Alterations in Noncerebral Falciparum Malaria.

Authors:  Sanjib Mohanty; Praveen K Sahu; Rajyabardhan Pattnaik; Megharay Majhi; Sameer Maharana; Jabamani Bage; Akshaya Mohanty; Anita Mohanty; Martin Bendszus; Catriona Patterson; Himanshu Gupta; Arjen M Dondorp; Lukas Pirpamer; Angelika Hoffmann; Samuel C Wassmer
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

6.  Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment.

Authors:  Minxian Dai; Brandi Freeman; Henry J Shikani; Fernando Pereira Bruno; J Elias Collado; Rolando Macias; Sandra E Reznik; Peter Davies; David Conover Spray; Herbert Bernard Tanowitz; Louis Martin Weiss; Mahalia Sabrina Desruisseaux
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

7.  Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial.

Authors:  Juliet Mwanga-Amumpaire; Ryan W Carroll; Elisabeth Baudin; Elisabeth Kemigisha; Dorah Nampijja; Kenneth Mworozi; Data Santorino; Dan Nyehangane; Daniel I Nathan; Pierre De Beaudrap; Jean-François Etard; Martin Feelisch; Bernadette O Fernandez; Annie Berssenbrugge; David Bangsberg; Kenneth D Bloch; Yap Boum; Warren M Zapol
Journal:  Open Forum Infect Dis       Date:  2015-07-24       Impact factor: 3.835

Review 8.  Predictors of outcome in childhood Plasmodium falciparum malaria.

Authors:  Harsita Patel; Claire Dunican; Aubrey J Cunnington
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

Review 9.  Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients.

Authors:  Steven T DeKosky; Patrick M Kochanek; Alex B Valadka; Robert S B Clark; Sherry H-Y Chou; Alicia K Au; Christopher Horvat; Ruchira M Jha; Rebekah Mannix; Stephen R Wisniewski; Max Wintermark; Susan E Rowell; Robert D Welch; Lawrence Lewis; Stacey House; Rudolph E Tanzi; Darci R Smith; Amy Y Vittor; Nancy D Denslow; Michael D Davis; Olena Y Glushakova; Ronald L Hayes
Journal:  J Neurotrauma       Date:  2020-11-11       Impact factor: 5.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.